Tvardi Therapeutics(DE:69C)
€1.10-0.07 (-5.98%)
DE:69C
Tvardi Therapeutics earnings date
€1.10
At close:-0.07 (-5.98%)
Tvardi Therapeutics (69C) Q3 2026 Earnings Report
1 Followers
DE:69C Q3 2026 EPS Results
- Actual EPS
- -EUR 0.48
- Consensus EPS
- -EUR 0.52
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.53
DE:69C Q3 2026 Revenue Results
- Actual Revenue
- ―
- Expected Revenue
- EUR 0
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/12/2026
- Time
- TBA
- Conference Call
- Thursday, November 12, 2026
DE:69C Upcoming Earnings
Tvardi Therapeutics's next earnings date is estimated for April 6, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:69C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 06, 2027 | 2026 (Q4) | ―- | -0.66 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.52-0.48 | -0.53 | 9.32% (+0.05) | |
| Aug 14, 2026 | 2026 (Q2) | -0.64-0.62 | -0.9 | 31.00% (+0.28) | |
| May 08, 2026 | 2026 (Q1) | ―- | -2.91 | ― | |
| Mar 31, 2026 | 2025 (Q4) | -0.67-0.66 | -2.91 | 77.33% (+2.25) | |
| Nov 13, 2025 | 2025 (Q3) | -0.90-0.53 | -7.4 | 92.80% (+6.87) | |
| Aug 14, 2025 | 2025 (Q2) | -0.62-0.90 | -11.9 | 92.41% (+11.00) | |
| May 13, 2025 | 2025 (Q1) | -0.53-2.91 | -18.22 | 84.03% (+15.31) | |
| Feb 26, 2025 | 2024 (Q4) | ―-1.52 | -6.4 | 76.27% (+4.88) | |
| Nov 04, 2024 | 2024 (Q3) | -0.22-0.21 | -0.47 | 56.15% (+0.26) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
